nodes	percent_of_prediction	percent_of_DWPC	metapath
Benazepril—MTHFR—Fluorouracil—pancreatic cancer	0.541	1	CbGbCtD
Benazepril—Benzyl Benzoate—Tamoxifen—pancreatic cancer	0.233	1	CrCrCtD
Benazepril—MTHFR—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00234	0.144	CbGpPWpGaD
Benazepril—ACE—ACE Inhibitor Pathway—AGTR1—pancreatic cancer	0.0013	0.0803	CbGpPWpGaD
Benazepril—MTHFR—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.00117	0.0725	CbGpPWpGaD
Benazepril—MTHFR—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000931	0.0575	CbGpPWpGaD
Benazepril—ACE—Peptide hormone metabolism—PCSK1—pancreatic cancer	0.000716	0.0442	CbGpPWpGaD
Benazepril—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—PRSS1—pancreatic cancer	0.000713	0.0441	CbGpPWpGaD
Benazepril—MTHFR—One Carbon Metabolism—TYMS—pancreatic cancer	0.000605	0.0374	CbGpPWpGaD
Benazepril—MTHFR—Trans-sulfuration and one carbon metabolism—TYMS—pancreatic cancer	0.000544	0.0336	CbGpPWpGaD
Benazepril—MTHFR—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.00053	0.0328	CbGpPWpGaD
Benazepril—ACE—ACE Inhibitor Pathway—TGFB1—pancreatic cancer	0.000444	0.0274	CbGpPWpGaD
Benazepril—ACE—Peptide hormone metabolism—GCG—pancreatic cancer	0.000376	0.0232	CbGpPWpGaD
Benazepril—MTHFR—Vitamin B12 Metabolism—SOD2—pancreatic cancer	0.000372	0.023	CbGpPWpGaD
Benazepril—SLC15A2—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000342	0.0211	CbGpPWpGaD
Benazepril—Hypotension—Irinotecan—pancreatic cancer	0.000337	0.00161	CcSEcCtD
Benazepril—Dizziness—Erlotinib—pancreatic cancer	0.000335	0.0016	CcSEcCtD
Benazepril—Erythema multiforme—Docetaxel—pancreatic cancer	0.000332	0.00159	CcSEcCtD
Benazepril—Face oedema—Epirubicin—pancreatic cancer	0.00033	0.00158	CcSEcCtD
Benazepril—Hypotension—Gemcitabine—pancreatic cancer	0.000328	0.00157	CcSEcCtD
Benazepril—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000327	0.00156	CcSEcCtD
Benazepril—Insomnia—Irinotecan—pancreatic cancer	0.000326	0.00156	CcSEcCtD
Benazepril—Flushing—Docetaxel—pancreatic cancer	0.000326	0.00156	CcSEcCtD
Benazepril—Vomiting—Tamoxifen—pancreatic cancer	0.000325	0.00155	CcSEcCtD
Benazepril—Paraesthesia—Irinotecan—pancreatic cancer	0.000324	0.00155	CcSEcCtD
Benazepril—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000323	0.00154	CcSEcCtD
Benazepril—Hypotension—Fluorouracil—pancreatic cancer	0.000323	0.00154	CcSEcCtD
Benazepril—Hypersensitivity—Sunitinib—pancreatic cancer	0.000323	0.00154	CcSEcCtD
Benazepril—Rash—Tamoxifen—pancreatic cancer	0.000322	0.00154	CcSEcCtD
Benazepril—Dermatitis—Tamoxifen—pancreatic cancer	0.000322	0.00154	CcSEcCtD
Benazepril—Vomiting—Erlotinib—pancreatic cancer	0.000322	0.00154	CcSEcCtD
Benazepril—Dyspnoea—Irinotecan—pancreatic cancer	0.000322	0.00154	CcSEcCtD
Benazepril—Somnolence—Irinotecan—pancreatic cancer	0.000321	0.00153	CcSEcCtD
Benazepril—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000321	0.00153	CcSEcCtD
Benazepril—Headache—Tamoxifen—pancreatic cancer	0.00032	0.00153	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.00032	0.00153	CcSEcCtD
Benazepril—Rash—Erlotinib—pancreatic cancer	0.000319	0.00152	CcSEcCtD
Benazepril—Dermatitis—Erlotinib—pancreatic cancer	0.000319	0.00152	CcSEcCtD
Benazepril—Hyponatraemia—Doxorubicin—pancreatic cancer	0.000318	0.00152	CcSEcCtD
Benazepril—Insomnia—Gemcitabine—pancreatic cancer	0.000318	0.00152	CcSEcCtD
Benazepril—Dyspepsia—Irinotecan—pancreatic cancer	0.000318	0.00152	CcSEcCtD
Benazepril—SLC15A1—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000317	0.0196	CbGpPWpGaD
Benazepril—Headache—Erlotinib—pancreatic cancer	0.000317	0.00151	CcSEcCtD
Benazepril—Paraesthesia—Gemcitabine—pancreatic cancer	0.000316	0.00151	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000315	0.0015	CcSEcCtD
Benazepril—Asthenia—Sunitinib—pancreatic cancer	0.000314	0.0015	CcSEcCtD
Benazepril—Arrhythmia—Docetaxel—pancreatic cancer	0.000314	0.0015	CcSEcCtD
Benazepril—Dyspnoea—Gemcitabine—pancreatic cancer	0.000313	0.0015	CcSEcCtD
Benazepril—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000313	0.00149	CcSEcCtD
Benazepril—Insomnia—Fluorouracil—pancreatic cancer	0.000313	0.00149	CcSEcCtD
Benazepril—Somnolence—Gemcitabine—pancreatic cancer	0.000312	0.00149	CcSEcCtD
Benazepril—Fatigue—Irinotecan—pancreatic cancer	0.000311	0.00149	CcSEcCtD
Benazepril—Paraesthesia—Fluorouracil—pancreatic cancer	0.00031	0.00148	CcSEcCtD
Benazepril—Alopecia—Docetaxel—pancreatic cancer	0.00031	0.00148	CcSEcCtD
Benazepril—Pruritus—Sunitinib—pancreatic cancer	0.00031	0.00148	CcSEcCtD
Benazepril—Constipation—Irinotecan—pancreatic cancer	0.000309	0.00147	CcSEcCtD
Benazepril—Dyspnoea—Fluorouracil—pancreatic cancer	0.000308	0.00147	CcSEcCtD
Benazepril—Somnolence—Fluorouracil—pancreatic cancer	0.000307	0.00147	CcSEcCtD
Benazepril—Face oedema—Doxorubicin—pancreatic cancer	0.000306	0.00146	CcSEcCtD
Benazepril—MTHFR—Vitamin B12 Metabolism—APOE—pancreatic cancer	0.000305	0.0188	CbGpPWpGaD
Benazepril—Dyspepsia—Fluorouracil—pancreatic cancer	0.000304	0.00145	CcSEcCtD
Benazepril—Nausea—Tamoxifen—pancreatic cancer	0.000304	0.00145	CcSEcCtD
Benazepril—Fatigue—Gemcitabine—pancreatic cancer	0.000303	0.00145	CcSEcCtD
Benazepril—Gastritis—Epirubicin—pancreatic cancer	0.000303	0.00145	CcSEcCtD
Benazepril—MTHFR—Folate Metabolism—SOD2—pancreatic cancer	0.000302	0.0187	CbGpPWpGaD
Benazepril—Constipation—Gemcitabine—pancreatic cancer	0.000301	0.00144	CcSEcCtD
Benazepril—Nausea—Erlotinib—pancreatic cancer	0.000301	0.00144	CcSEcCtD
Benazepril—Diarrhoea—Sunitinib—pancreatic cancer	0.0003	0.00143	CcSEcCtD
Benazepril—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000297	0.00142	CcSEcCtD
Benazepril—Asthma—Epirubicin—pancreatic cancer	0.000296	0.00141	CcSEcCtD
Benazepril—Influenza—Epirubicin—pancreatic cancer	0.000296	0.00141	CcSEcCtD
Benazepril—Back pain—Docetaxel—pancreatic cancer	0.000296	0.00141	CcSEcCtD
Benazepril—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000295	0.00141	CcSEcCtD
Benazepril—Eosinophilia—Epirubicin—pancreatic cancer	0.000293	0.0014	CcSEcCtD
Benazepril—Pancreatitis—Epirubicin—pancreatic cancer	0.00029	0.00139	CcSEcCtD
Benazepril—Dizziness—Sunitinib—pancreatic cancer	0.00029	0.00138	CcSEcCtD
Benazepril—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000289	0.00138	CcSEcCtD
Benazepril—Angina pectoris—Epirubicin—pancreatic cancer	0.000288	0.00138	CcSEcCtD
Benazepril—Abdominal pain—Irinotecan—pancreatic cancer	0.000285	0.00136	CcSEcCtD
Benazepril—Bronchitis—Epirubicin—pancreatic cancer	0.000284	0.00136	CcSEcCtD
Benazepril—Gastritis—Doxorubicin—pancreatic cancer	0.00028	0.00134	CcSEcCtD
Benazepril—Vomiting—Sunitinib—pancreatic cancer	0.000278	0.00133	CcSEcCtD
Benazepril—Neutropenia—Epirubicin—pancreatic cancer	0.000277	0.00132	CcSEcCtD
Benazepril—Rash—Sunitinib—pancreatic cancer	0.000276	0.00132	CcSEcCtD
Benazepril—Dermatitis—Sunitinib—pancreatic cancer	0.000276	0.00132	CcSEcCtD
Benazepril—Headache—Sunitinib—pancreatic cancer	0.000274	0.00131	CcSEcCtD
Benazepril—Syncope—Docetaxel—pancreatic cancer	0.000274	0.00131	CcSEcCtD
Benazepril—Asthma—Doxorubicin—pancreatic cancer	0.000274	0.00131	CcSEcCtD
Benazepril—Influenza—Doxorubicin—pancreatic cancer	0.000274	0.00131	CcSEcCtD
Benazepril—Leukopenia—Docetaxel—pancreatic cancer	0.000274	0.00131	CcSEcCtD
Benazepril—Pollakiuria—Epirubicin—pancreatic cancer	0.000273	0.00131	CcSEcCtD
Benazepril—Eosinophilia—Doxorubicin—pancreatic cancer	0.000271	0.0013	CcSEcCtD
Benazepril—Palpitations—Docetaxel—pancreatic cancer	0.00027	0.00129	CcSEcCtD
Benazepril—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.00027	0.00129	CcSEcCtD
Benazepril—Loss of consciousness—Docetaxel—pancreatic cancer	0.000269	0.00128	CcSEcCtD
Benazepril—Pancreatitis—Doxorubicin—pancreatic cancer	0.000268	0.00128	CcSEcCtD
Benazepril—Cough—Docetaxel—pancreatic cancer	0.000267	0.00127	CcSEcCtD
Benazepril—Angina pectoris—Doxorubicin—pancreatic cancer	0.000267	0.00127	CcSEcCtD
Benazepril—Hypersensitivity—Irinotecan—pancreatic cancer	0.000266	0.00127	CcSEcCtD
Benazepril—Bronchitis—Doxorubicin—pancreatic cancer	0.000263	0.00126	CcSEcCtD
Benazepril—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000261	0.00125	CcSEcCtD
Benazepril—Chest pain—Docetaxel—pancreatic cancer	0.00026	0.00124	CcSEcCtD
Benazepril—Myalgia—Docetaxel—pancreatic cancer	0.00026	0.00124	CcSEcCtD
Benazepril—Arthralgia—Docetaxel—pancreatic cancer	0.00026	0.00124	CcSEcCtD
Benazepril—Nausea—Sunitinib—pancreatic cancer	0.00026	0.00124	CcSEcCtD
Benazepril—Asthenia—Irinotecan—pancreatic cancer	0.000259	0.00124	CcSEcCtD
Benazepril—Urinary tract infection—Epirubicin—pancreatic cancer	0.000256	0.00123	CcSEcCtD
Benazepril—Neutropenia—Doxorubicin—pancreatic cancer	0.000256	0.00122	CcSEcCtD
Benazepril—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000255	0.00122	CcSEcCtD
Benazepril—Sweating—Epirubicin—pancreatic cancer	0.000253	0.00121	CcSEcCtD
Benazepril—Pollakiuria—Doxorubicin—pancreatic cancer	0.000253	0.00121	CcSEcCtD
Benazepril—Asthenia—Gemcitabine—pancreatic cancer	0.000252	0.0012	CcSEcCtD
Benazepril—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.00025	0.00119	CcSEcCtD
Benazepril—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000249	0.00119	CcSEcCtD
Benazepril—Oedema—Docetaxel—pancreatic cancer	0.000249	0.00119	CcSEcCtD
Benazepril—Pruritus—Gemcitabine—pancreatic cancer	0.000249	0.00119	CcSEcCtD
Benazepril—Infection—Docetaxel—pancreatic cancer	0.000248	0.00118	CcSEcCtD
Benazepril—Sinusitis—Epirubicin—pancreatic cancer	0.000247	0.00118	CcSEcCtD
Benazepril—Diarrhoea—Irinotecan—pancreatic cancer	0.000247	0.00118	CcSEcCtD
Benazepril—Agranulocytosis—Epirubicin—pancreatic cancer	0.000246	0.00118	CcSEcCtD
Benazepril—Shock—Docetaxel—pancreatic cancer	0.000245	0.00117	CcSEcCtD
Benazepril—Pruritus—Fluorouracil—pancreatic cancer	0.000244	0.00117	CcSEcCtD
Benazepril—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000244	0.00117	CcSEcCtD
Benazepril—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000242	0.00116	CcSEcCtD
Benazepril—Diarrhoea—Gemcitabine—pancreatic cancer	0.00024	0.00115	CcSEcCtD
Benazepril—MTHFR—Selenium Micronutrient Network—SOD2—pancreatic cancer	0.00024	0.0148	CbGpPWpGaD
Benazepril—Dizziness—Irinotecan—pancreatic cancer	0.000239	0.00114	CcSEcCtD
Benazepril—Rhinitis—Epirubicin—pancreatic cancer	0.000237	0.00113	CcSEcCtD
Benazepril—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000237	0.00113	CcSEcCtD
Benazepril—Hepatitis—Epirubicin—pancreatic cancer	0.000237	0.00113	CcSEcCtD
Benazepril—Diarrhoea—Fluorouracil—pancreatic cancer	0.000236	0.00113	CcSEcCtD
Benazepril—Pharyngitis—Epirubicin—pancreatic cancer	0.000235	0.00112	CcSEcCtD
Benazepril—Sweating—Doxorubicin—pancreatic cancer	0.000234	0.00112	CcSEcCtD
Benazepril—Oedema peripheral—Epirubicin—pancreatic cancer	0.000233	0.00111	CcSEcCtD
Benazepril—Hypotension—Docetaxel—pancreatic cancer	0.000233	0.00111	CcSEcCtD
Benazepril—Vomiting—Irinotecan—pancreatic cancer	0.000229	0.0011	CcSEcCtD
Benazepril—Sinusitis—Doxorubicin—pancreatic cancer	0.000229	0.00109	CcSEcCtD
Benazepril—Dizziness—Fluorouracil—pancreatic cancer	0.000229	0.00109	CcSEcCtD
Benazepril—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000228	0.00109	CcSEcCtD
Benazepril—Rash—Irinotecan—pancreatic cancer	0.000227	0.00109	CcSEcCtD
Benazepril—Dermatitis—Irinotecan—pancreatic cancer	0.000227	0.00109	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000227	0.00109	CcSEcCtD
Benazepril—Headache—Irinotecan—pancreatic cancer	0.000226	0.00108	CcSEcCtD
Benazepril—Insomnia—Docetaxel—pancreatic cancer	0.000226	0.00108	CcSEcCtD
Benazepril—Paraesthesia—Docetaxel—pancreatic cancer	0.000224	0.00107	CcSEcCtD
Benazepril—Erythema multiforme—Epirubicin—pancreatic cancer	0.000224	0.00107	CcSEcCtD
Benazepril—Vomiting—Gemcitabine—pancreatic cancer	0.000223	0.00107	CcSEcCtD
Benazepril—Dyspnoea—Docetaxel—pancreatic cancer	0.000222	0.00106	CcSEcCtD
Benazepril—Somnolence—Docetaxel—pancreatic cancer	0.000222	0.00106	CcSEcCtD
Benazepril—Rash—Gemcitabine—pancreatic cancer	0.000222	0.00106	CcSEcCtD
Benazepril—Dermatitis—Gemcitabine—pancreatic cancer	0.000221	0.00106	CcSEcCtD
Benazepril—ACE—Metabolism of proteins—FUT8—pancreatic cancer	0.000221	0.0137	CbGpPWpGaD
Benazepril—Tinnitus—Epirubicin—pancreatic cancer	0.000221	0.00105	CcSEcCtD
Benazepril—Headache—Gemcitabine—pancreatic cancer	0.00022	0.00105	CcSEcCtD
Benazepril—Flushing—Epirubicin—pancreatic cancer	0.00022	0.00105	CcSEcCtD
Benazepril—Vomiting—Fluorouracil—pancreatic cancer	0.00022	0.00105	CcSEcCtD
Benazepril—Rhinitis—Doxorubicin—pancreatic cancer	0.00022	0.00105	CcSEcCtD
Benazepril—Dyspepsia—Docetaxel—pancreatic cancer	0.00022	0.00105	CcSEcCtD
Benazepril—Hepatitis—Doxorubicin—pancreatic cancer	0.000219	0.00105	CcSEcCtD
Benazepril—Rash—Fluorouracil—pancreatic cancer	0.000218	0.00104	CcSEcCtD
Benazepril—Dermatitis—Fluorouracil—pancreatic cancer	0.000218	0.00104	CcSEcCtD
Benazepril—Pharyngitis—Doxorubicin—pancreatic cancer	0.000217	0.00104	CcSEcCtD
Benazepril—Headache—Fluorouracil—pancreatic cancer	0.000216	0.00103	CcSEcCtD
Benazepril—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000216	0.00103	CcSEcCtD
Benazepril—Fatigue—Docetaxel—pancreatic cancer	0.000215	0.00103	CcSEcCtD
Benazepril—Nausea—Irinotecan—pancreatic cancer	0.000214	0.00102	CcSEcCtD
Benazepril—Constipation—Docetaxel—pancreatic cancer	0.000213	0.00102	CcSEcCtD
Benazepril—SLC15A2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000213	0.0132	CbGpPWpGaD
Benazepril—Arrhythmia—Epirubicin—pancreatic cancer	0.000212	0.00101	CcSEcCtD
Benazepril—Alopecia—Epirubicin—pancreatic cancer	0.000209	0.001	CcSEcCtD
Benazepril—Nausea—Gemcitabine—pancreatic cancer	0.000209	0.000998	CcSEcCtD
Benazepril—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000207	0.00099	CcSEcCtD
Benazepril—Nausea—Fluorouracil—pancreatic cancer	0.000205	0.000981	CcSEcCtD
Benazepril—Tinnitus—Doxorubicin—pancreatic cancer	0.000204	0.000976	CcSEcCtD
Benazepril—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000204	0.000975	CcSEcCtD
Benazepril—Flushing—Doxorubicin—pancreatic cancer	0.000203	0.000972	CcSEcCtD
Benazepril—Flatulence—Epirubicin—pancreatic cancer	0.000203	0.000971	CcSEcCtD
Benazepril—Tension—Epirubicin—pancreatic cancer	0.000202	0.000967	CcSEcCtD
Benazepril—Nervousness—Epirubicin—pancreatic cancer	0.0002	0.000957	CcSEcCtD
Benazepril—Back pain—Epirubicin—pancreatic cancer	0.000199	0.000953	CcSEcCtD
Benazepril—SLC15A1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000198	0.0122	CbGpPWpGaD
Benazepril—Abdominal pain—Docetaxel—pancreatic cancer	0.000197	0.000942	CcSEcCtD
Benazepril—Arrhythmia—Doxorubicin—pancreatic cancer	0.000196	0.000935	CcSEcCtD
Benazepril—Alopecia—Doxorubicin—pancreatic cancer	0.000194	0.000925	CcSEcCtD
Benazepril—Flatulence—Doxorubicin—pancreatic cancer	0.000188	0.000898	CcSEcCtD
Benazepril—Tension—Doxorubicin—pancreatic cancer	0.000187	0.000894	CcSEcCtD
Benazepril—Nervousness—Doxorubicin—pancreatic cancer	0.000185	0.000885	CcSEcCtD
Benazepril—Vertigo—Epirubicin—pancreatic cancer	0.000185	0.000885	CcSEcCtD
Benazepril—Syncope—Epirubicin—pancreatic cancer	0.000185	0.000883	CcSEcCtD
Benazepril—Leukopenia—Epirubicin—pancreatic cancer	0.000185	0.000882	CcSEcCtD
Benazepril—Back pain—Doxorubicin—pancreatic cancer	0.000184	0.000882	CcSEcCtD
Benazepril—Hypersensitivity—Docetaxel—pancreatic cancer	0.000184	0.000878	CcSEcCtD
Benazepril—Palpitations—Epirubicin—pancreatic cancer	0.000182	0.00087	CcSEcCtD
Benazepril—Loss of consciousness—Epirubicin—pancreatic cancer	0.000181	0.000866	CcSEcCtD
Benazepril—Cough—Epirubicin—pancreatic cancer	0.00018	0.00086	CcSEcCtD
Benazepril—Asthenia—Docetaxel—pancreatic cancer	0.000179	0.000855	CcSEcCtD
Benazepril—Pruritus—Docetaxel—pancreatic cancer	0.000176	0.000843	CcSEcCtD
Benazepril—MTHFR—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000176	0.0109	CbGpPWpGaD
Benazepril—Chest pain—Epirubicin—pancreatic cancer	0.000175	0.000839	CcSEcCtD
Benazepril—Arthralgia—Epirubicin—pancreatic cancer	0.000175	0.000839	CcSEcCtD
Benazepril—Myalgia—Epirubicin—pancreatic cancer	0.000175	0.000839	CcSEcCtD
Benazepril—Anxiety—Epirubicin—pancreatic cancer	0.000175	0.000836	CcSEcCtD
Benazepril—SLC15A2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000174	0.0107	CbGpPWpGaD
Benazepril—Vertigo—Doxorubicin—pancreatic cancer	0.000171	0.000819	CcSEcCtD
Benazepril—Syncope—Doxorubicin—pancreatic cancer	0.000171	0.000817	CcSEcCtD
Benazepril—Leukopenia—Doxorubicin—pancreatic cancer	0.000171	0.000816	CcSEcCtD
Benazepril—Diarrhoea—Docetaxel—pancreatic cancer	0.000171	0.000815	CcSEcCtD
Benazepril—Palpitations—Doxorubicin—pancreatic cancer	0.000169	0.000805	CcSEcCtD
Benazepril—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000168	0.000804	CcSEcCtD
Benazepril—Oedema—Epirubicin—pancreatic cancer	0.000168	0.000804	CcSEcCtD
Benazepril—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000168	0.000801	CcSEcCtD
Benazepril—Infection—Epirubicin—pancreatic cancer	0.000167	0.000799	CcSEcCtD
Benazepril—Cough—Doxorubicin—pancreatic cancer	0.000166	0.000795	CcSEcCtD
Benazepril—Shock—Epirubicin—pancreatic cancer	0.000166	0.000791	CcSEcCtD
Benazepril—Dizziness—Docetaxel—pancreatic cancer	0.000165	0.000788	CcSEcCtD
Benazepril—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000165	0.000787	CcSEcCtD
Benazepril—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000163	0.000777	CcSEcCtD
Benazepril—Arthralgia—Doxorubicin—pancreatic cancer	0.000162	0.000776	CcSEcCtD
Benazepril—Myalgia—Doxorubicin—pancreatic cancer	0.000162	0.000776	CcSEcCtD
Benazepril—Chest pain—Doxorubicin—pancreatic cancer	0.000162	0.000776	CcSEcCtD
Benazepril—Anxiety—Doxorubicin—pancreatic cancer	0.000162	0.000773	CcSEcCtD
Benazepril—SLC15A1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000161	0.00997	CbGpPWpGaD
Benazepril—Vomiting—Docetaxel—pancreatic cancer	0.000159	0.000758	CcSEcCtD
Benazepril—Rash—Docetaxel—pancreatic cancer	0.000157	0.000751	CcSEcCtD
Benazepril—Hypotension—Epirubicin—pancreatic cancer	0.000157	0.000751	CcSEcCtD
Benazepril—Dermatitis—Docetaxel—pancreatic cancer	0.000157	0.000751	CcSEcCtD
Benazepril—Headache—Docetaxel—pancreatic cancer	0.000156	0.000747	CcSEcCtD
Benazepril—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000156	0.000744	CcSEcCtD
Benazepril—Oedema—Doxorubicin—pancreatic cancer	0.000156	0.000744	CcSEcCtD
Benazepril—Infection—Doxorubicin—pancreatic cancer	0.000155	0.000739	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000153	0.000732	CcSEcCtD
Benazepril—Shock—Doxorubicin—pancreatic cancer	0.000153	0.000732	CcSEcCtD
Benazepril—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000152	0.000728	CcSEcCtD
Benazepril—Insomnia—Epirubicin—pancreatic cancer	0.000152	0.000727	CcSEcCtD
Benazepril—ACE—Peptide hormone metabolism—CTNNB1—pancreatic cancer	0.000152	0.00937	CbGpPWpGaD
Benazepril—Paraesthesia—Epirubicin—pancreatic cancer	0.000151	0.000722	CcSEcCtD
Benazepril—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.00015	0.000719	CcSEcCtD
Benazepril—Dyspnoea—Epirubicin—pancreatic cancer	0.00015	0.000717	CcSEcCtD
Benazepril—Somnolence—Epirubicin—pancreatic cancer	0.00015	0.000715	CcSEcCtD
Benazepril—Nausea—Docetaxel—pancreatic cancer	0.000148	0.000708	CcSEcCtD
Benazepril—Dyspepsia—Epirubicin—pancreatic cancer	0.000148	0.000708	CcSEcCtD
Benazepril—Hypotension—Doxorubicin—pancreatic cancer	0.000145	0.000695	CcSEcCtD
Benazepril—Fatigue—Epirubicin—pancreatic cancer	0.000145	0.000693	CcSEcCtD
Benazepril—Constipation—Epirubicin—pancreatic cancer	0.000144	0.000687	CcSEcCtD
Benazepril—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000142	0.000678	CcSEcCtD
Benazepril—MTHFR—Vitamin B12 Metabolism—TNF—pancreatic cancer	0.000141	0.0087	CbGpPWpGaD
Benazepril—Insomnia—Doxorubicin—pancreatic cancer	0.000141	0.000673	CcSEcCtD
Benazepril—Paraesthesia—Doxorubicin—pancreatic cancer	0.00014	0.000668	CcSEcCtD
Benazepril—Dyspnoea—Doxorubicin—pancreatic cancer	0.000139	0.000663	CcSEcCtD
Benazepril—Somnolence—Doxorubicin—pancreatic cancer	0.000138	0.000661	CcSEcCtD
Benazepril—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000138	0.000657	CcSEcCtD
Benazepril—Dyspepsia—Doxorubicin—pancreatic cancer	0.000137	0.000655	CcSEcCtD
Benazepril—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—pancreatic cancer	0.000136	0.00841	CbGpPWpGaD
Benazepril—ACE—Metabolism of proteins—PCSK1—pancreatic cancer	0.000135	0.00835	CbGpPWpGaD
Benazepril—MTHFR—Selenium Micronutrient Network—PTGS2—pancreatic cancer	0.000135	0.00833	CbGpPWpGaD
Benazepril—Fatigue—Doxorubicin—pancreatic cancer	0.000134	0.000641	CcSEcCtD
Benazepril—Constipation—Doxorubicin—pancreatic cancer	0.000133	0.000636	CcSEcCtD
Benazepril—Abdominal pain—Epirubicin—pancreatic cancer	0.000133	0.000635	CcSEcCtD
Benazepril—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000129	0.00798	CbGpPWpGaD
Benazepril—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000127	0.000608	CcSEcCtD
Benazepril—Hypersensitivity—Epirubicin—pancreatic cancer	0.000124	0.000592	CcSEcCtD
Benazepril—ACE—Metabolism of proteins—PPP2R5B—pancreatic cancer	0.000124	0.00764	CbGpPWpGaD
Benazepril—Abdominal pain—Doxorubicin—pancreatic cancer	0.000123	0.000588	CcSEcCtD
Benazepril—Asthenia—Epirubicin—pancreatic cancer	0.000121	0.000577	CcSEcCtD
Benazepril—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.00012	0.00741	CbGpPWpGaD
Benazepril—Pruritus—Epirubicin—pancreatic cancer	0.000119	0.000569	CcSEcCtD
Benazepril—Diarrhoea—Epirubicin—pancreatic cancer	0.000115	0.00055	CcSEcCtD
Benazepril—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000115	0.000548	CcSEcCtD
Benazepril—MTHFR—Folate Metabolism—TNF—pancreatic cancer	0.000115	0.00708	CbGpPWpGaD
Benazepril—Asthenia—Doxorubicin—pancreatic cancer	0.000112	0.000534	CcSEcCtD
Benazepril—Dizziness—Epirubicin—pancreatic cancer	0.000111	0.000532	CcSEcCtD
Benazepril—Pruritus—Doxorubicin—pancreatic cancer	0.00011	0.000526	CcSEcCtD
Benazepril—Vomiting—Epirubicin—pancreatic cancer	0.000107	0.000511	CcSEcCtD
Benazepril—Diarrhoea—Doxorubicin—pancreatic cancer	0.000106	0.000509	CcSEcCtD
Benazepril—Rash—Epirubicin—pancreatic cancer	0.000106	0.000507	CcSEcCtD
Benazepril—Dermatitis—Epirubicin—pancreatic cancer	0.000106	0.000506	CcSEcCtD
Benazepril—Headache—Epirubicin—pancreatic cancer	0.000105	0.000504	CcSEcCtD
Benazepril—Dizziness—Doxorubicin—pancreatic cancer	0.000103	0.000492	CcSEcCtD
Benazepril—MTHFR—Folate Metabolism—TP53—pancreatic cancer	0.000101	0.00624	CbGpPWpGaD
Benazepril—Nausea—Epirubicin—pancreatic cancer	9.99e-05	0.000478	CcSEcCtD
Benazepril—Vomiting—Doxorubicin—pancreatic cancer	9.9e-05	0.000473	CcSEcCtD
Benazepril—Rash—Doxorubicin—pancreatic cancer	9.81e-05	0.000469	CcSEcCtD
Benazepril—Dermatitis—Doxorubicin—pancreatic cancer	9.81e-05	0.000469	CcSEcCtD
Benazepril—Headache—Doxorubicin—pancreatic cancer	9.75e-05	0.000466	CcSEcCtD
Benazepril—Nausea—Doxorubicin—pancreatic cancer	9.25e-05	0.000442	CcSEcCtD
Benazepril—MTHFR—Selenium Micronutrient Network—TNF—pancreatic cancer	9.11e-05	0.00563	CbGpPWpGaD
Benazepril—MTHFR—Disease—PRSS1—pancreatic cancer	8.44e-05	0.00522	CbGpPWpGaD
Benazepril—MTHFR—Disease—ZNRF3—pancreatic cancer	8.44e-05	0.00522	CbGpPWpGaD
Benazepril—MTHFR—Disease—DTX1—pancreatic cancer	7.64e-05	0.00472	CbGpPWpGaD
Benazepril—ACE—Metabolism of proteins—GCG—pancreatic cancer	7.1e-05	0.00439	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—PRSS1—pancreatic cancer	7.07e-05	0.00437	CbGpPWpGaD
Benazepril—SLC15A2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.56e-05	0.00406	CbGpPWpGaD
Benazepril—MTHFR—Disease—DTX4—pancreatic cancer	6.4e-05	0.00395	CbGpPWpGaD
Benazepril—MTHFR—Disease—PPP2R5B—pancreatic cancer	6.22e-05	0.00385	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—ARG2—pancreatic cancer	6.13e-05	0.00379	CbGpPWpGaD
Benazepril—SLC15A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.09e-05	0.00376	CbGpPWpGaD
Benazepril—MTHFR—Disease—HEY2—pancreatic cancer	5.99e-05	0.0037	CbGpPWpGaD
Benazepril—MTHFR—Disease—HEY1—pancreatic cancer	5.55e-05	0.00343	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—TYMP—pancreatic cancer	5.36e-05	0.00331	CbGpPWpGaD
Benazepril—MTHFR—Disease—JAG2—pancreatic cancer	4.92e-05	0.00304	CbGpPWpGaD
Benazepril—MTHFR—Disease—MEN1—pancreatic cancer	4.85e-05	0.003	CbGpPWpGaD
Benazepril—MTHFR—Disease—SLC2A2—pancreatic cancer	4.81e-05	0.00298	CbGpPWpGaD
Benazepril—MTHFR—Disease—SHH—pancreatic cancer	4.63e-05	0.00286	CbGpPWpGaD
Benazepril—MTHFR—Disease—IAPP—pancreatic cancer	4.57e-05	0.00282	CbGpPWpGaD
Benazepril—MTHFR—Disease—HSPA1B—pancreatic cancer	4.39e-05	0.00271	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—GLP1R—pancreatic cancer	4.32e-05	0.00267	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—DPYD—pancreatic cancer	4.25e-05	0.00263	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—SLC2A2—pancreatic cancer	4.03e-05	0.00249	CbGpPWpGaD
Benazepril—MTHFR—Disease—JAG1—pancreatic cancer	3.93e-05	0.00243	CbGpPWpGaD
Benazepril—ACE—Metabolism of proteins—MMP2—pancreatic cancer	3.73e-05	0.00231	CbGpPWpGaD
Benazepril—MTHFR—Disease—CD44—pancreatic cancer	3.73e-05	0.0023	CbGpPWpGaD
Benazepril—MTHFR—Disease—HSPA1A—pancreatic cancer	3.7e-05	0.00229	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—CD44—pancreatic cancer	3.12e-05	0.00193	CbGpPWpGaD
Benazepril—ACE—Metabolism of proteins—CXCL8—pancreatic cancer	3.1e-05	0.00192	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—GCG—pancreatic cancer	2.99e-05	0.00185	CbGpPWpGaD
Benazepril—MTHFR—Disease—SMAD4—pancreatic cancer	2.94e-05	0.00182	CbGpPWpGaD
Benazepril—MTHFR—Disease—HES1—pancreatic cancer	2.87e-05	0.00178	CbGpPWpGaD
Benazepril—ACE—Metabolism of proteins—CTNNB1—pancreatic cancer	2.86e-05	0.00177	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—STK11—pancreatic cancer	2.81e-05	0.00174	CbGpPWpGaD
Benazepril—MTHFR—Disease—TERT—pancreatic cancer	2.52e-05	0.00156	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—TYMS—pancreatic cancer	2.42e-05	0.0015	CbGpPWpGaD
Benazepril—MTHFR—Disease—HIF1A—pancreatic cancer	2.41e-05	0.00149	CbGpPWpGaD
Benazepril—MTHFR—Disease—TSC2—pancreatic cancer	2.4e-05	0.00148	CbGpPWpGaD
Benazepril—MTHFR—Disease—APOE—pancreatic cancer	2.35e-05	0.00145	CbGpPWpGaD
Benazepril—MTHFR—Disease—NOTCH1—pancreatic cancer	2.17e-05	0.00134	CbGpPWpGaD
Benazepril—MTHFR—Disease—EGF—pancreatic cancer	2.1e-05	0.0013	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—APOE—pancreatic cancer	1.97e-05	0.00122	CbGpPWpGaD
Benazepril—MTHFR—Disease—PIK3CD—pancreatic cancer	1.87e-05	0.00115	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—PIK3CG—pancreatic cancer	1.78e-05	0.0011	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—PPARG—pancreatic cancer	1.72e-05	0.00106	CbGpPWpGaD
Benazepril—MTHFR—Disease—PIK3CB—pancreatic cancer	1.63e-05	0.001	CbGpPWpGaD
Benazepril—MTHFR—Disease—PTGS2—pancreatic cancer	1.61e-05	0.000996	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—PIK3CD—pancreatic cancer	1.56e-05	0.000965	CbGpPWpGaD
Benazepril—MTHFR—Disease—CTNNB1—pancreatic cancer	1.44e-05	0.000891	CbGpPWpGaD
Benazepril—MTHFR—Disease—PTEN—pancreatic cancer	1.41e-05	0.000868	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—PIK3CB—pancreatic cancer	1.36e-05	0.000842	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—PTGS2—pancreatic cancer	1.35e-05	0.000834	CbGpPWpGaD
Benazepril—MTHFR—Disease—SRC—pancreatic cancer	1.3e-05	0.000805	CbGpPWpGaD
Benazepril—MTHFR—Disease—STAT3—pancreatic cancer	1.26e-05	0.000777	CbGpPWpGaD
Benazepril—MTHFR—Disease—NRAS—pancreatic cancer	1.25e-05	0.000775	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—PTEN—pancreatic cancer	1.18e-05	0.000727	CbGpPWpGaD
Benazepril—MTHFR—Disease—MYC—pancreatic cancer	1.17e-05	0.000722	CbGpPWpGaD
Benazepril—MTHFR—Disease—TGFB1—pancreatic cancer	1.16e-05	0.00072	CbGpPWpGaD
Benazepril—MTHFR—Disease—EGFR—pancreatic cancer	1.14e-05	0.000706	CbGpPWpGaD
Benazepril—MTHFR—Disease—KRAS—pancreatic cancer	1.08e-05	0.000667	CbGpPWpGaD
Benazepril—MTHFR—Disease—PIK3CA—pancreatic cancer	9.91e-06	0.000613	CbGpPWpGaD
Benazepril—MTHFR—Disease—HRAS—pancreatic cancer	9.17e-06	0.000567	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—PIK3CA—pancreatic cancer	8.3e-06	0.000513	CbGpPWpGaD
Benazepril—MTHFR—Disease—AKT1—pancreatic cancer	8.1e-06	0.0005	CbGpPWpGaD
Benazepril—MTHFR—Metabolism—AKT1—pancreatic cancer	6.78e-06	0.000419	CbGpPWpGaD
